Clinical Protocol for a Phase II Open-label, Multicenter Long-term Extension Study to Assess the Long-term Safety and Efficacy of Vamorolone in Boys with Duchenne Muscular Dystrophy (DMD)

Administered By

Awarded By

Contributors

Start/End

  • January 20, 2017 - December 31, 2020